
Innomet Advanced Materials Approves Preferential Warrant Issue, ESOP, and Appoints Key Managerial Personnel
Innomet Advanced Materials Ltd. announced several key operational and corporate decisions following a Board meeting held on August 24, 2026. The Board considered and approved the issuance of equity share warrants, the launch of a new Employee Stock Option Scheme (ESOP), and the appointment of a Key Managerial Personnel (KMP).One of the major decisions involved the creation, issuance, and offer of Equity Share Warrants to the non-promoter category. The company approved the issuance of up to 11,92,200 warrants at a price of Rs. 210.00 per warrant, with an aggregate issue amount estimated at approximately Rs. 25,03,62,000. The allotment is directed toward Mr. Mukul Mahavir Agrawal, a non-promoter investor.
The warrants are fully convertible into an equal number of equity shares at the option of the warrant holder. The terms stipulate that the warrants can be exercised over a period of 18 months from the date of allotment. At the time of subscription, an amount equivalent to 25% of the warrant issue price is payable, and the remaining 75% is due at the time of exercise.
Key details regarding the preferential allotment are summarized below:
| Particulars | Details |
|---|---|
| Type of Securities | Equity Share Warrants |
| Total Issue Size | Up to 11,92,200 Equity Share Warrants |
| Issue Price | Rs. 210.00 per warrant |
| Aggregate Issue Amount | Approximately Rs. 25,03,62,000 |
| Investor | Mr. Mukul Mahavir Agrawal (Non-Promoter) |
| Conversion Term | 18 months from allotment |
Employee Stock Option Scheme (ESOP 2026) Launched
The Board also sanctioned the Innomet Advanced Materials Limited Employee Stock Option Scheme 2026 (Innomet ESOP 2026). The scheme is designed for the grant of stock options to eligible employees of the Company, its current subsidiaries, and future subsidiaries.The total number of shares covered under the ESOP is set at 2,60,000. The Exercise Price for the options will be determined by the Nomination and Remuneration Committee and must be no less than the face value of the Company's shares. The Exercise Period for vested options is a maximum of 2 years from the date of vesting, with a minimum vesting period of one year.
Details of the ESOP are as follows:
| Particulars | Details |
|---|---|
| Scheme Name | Innomet ESOP 2026 |
| Total Shares Covered | 2,60,000 |
| Minimum Vesting Period | 1 year |
| Maximum Exercise Period | 2 years from vesting date |
New KMP Appointed
The Board of Directors also approved the appointment of Ms. Y.K.Priyadarshini as a Key Managerial Personnel (KMP), serving as the Company Secretary and Compliance Officer. The appointment is effective from August 27, 2026.Ms. Priyadarshini is a qualified Company Secretary and an Associate Member of the Institute of Company Secretaries of India (ICSI). She possesses over 12 years of professional experience in corporate secretarial and compliance functions. Her areas of expertise include SEBI regulations and compliances (LODR, SAST, PIT, ICDR), FEMA and RBI compliances, corporate restructuring, and IPO preparedness.
Annual General Meeting Scheduled
The company's Board approved the convening of the Annual General Meeting (AGM) on Tuesday, September 22, 2026. The AGM will be conducted through Video Conferencing (VC) or other Audio Visual Means (OAVM) to seek shareholder approval for the various items approved by the Board.Additionally, the Board approved the Board's Report for the financial year 2025-26.
INNOMET Stock Price Movement
Innomet Advanced Materials Limited stock surged in post-market trading today, closing at ₹236.55 as it achieved a significant career milestone. The successful close saw the equity hit its 52-week high, with total traded volume recorded at 15,000 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.